PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Kadir, A.; Darreh-Shori, T.; Almkvist, O.; Wall, A.; Grut, M.; Strandberg, B.; Ringheim, A.; B. Eriksson,; Blomquist, G.; Långström, B.; Nordberg, A.

doi:10.1016/j.neurobiolaging.2007.02.020

« Previous Next »Neurobiology of Aging
Volume 29, Issue 8 , Pages 1204-1217, August 2008

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

A. Kadir
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
T. Darreh-Shori
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
O. Almkvist
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
- Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
- Department of Psychology, Stockholm University, Sweden
A. Wall
- Uppsala PET Centre/Uppsala Imanet, Uppsala, Sweden
M. Grut
- Geriatrics Clinic, Danderyd Hospital, Stockholm, Sweden
B. Strandberg
- Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
A. Ringheim
- Uppsala PET Centre/Uppsala Imanet, Uppsala, Sweden
B. Eriksson
- Janssen-Cilag, Sollentuna, Sweden
G. Blomquist
- Uppsala PET Centre/Uppsala Imanet, Uppsala, Sweden
- Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Sweden
B. Långström
- Uppsala PET Centre/Uppsala Imanet, Uppsala, Sweden
A. Nordberg
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
- Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
- Corresponding author at: Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Division of Molecular Neuropharmacology, Karolinska University Hospital Huddinge, Novum Floor-5, S-141 86 Stockholm, Sweden. Tel.: +46 8 585 854 67; fax: +46 8 585 854 70.